INTERNATIONAL PATENT: DEWPOINT THERAPEUTICS, INC. FILES APPLICATION FOR "THIENOPYRIDINE COMPOUNDS AND USES THEREOF"

GENEVA, July 14 -- DEWPOINT THERAPEUTICS, INC. (451 D Street, Suite 104Boston, Massachusetts 02210) filed a patent application (PCT/US2025/010226) for "THIENOPYRIDINE COMPOUNDS AND USES THEREOF" on Jan 03, 2025. With publication no. WO/2025/147603, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RIGUET, Eric (c/o Dewpoint Therapeutics GmbHTatzberg 4701307 Dresden), WAGNER, Michael (c/o Dewpoint Therapeutics GmbHTatzberg 4701307 Dresden), MARTINEZ, Eduardo J. (c/o Dewpoint Therapeutics, Inc.451 D Street, Suite 104Boston, M...